Literature DB >> 8432318

Acute respiratory illness in the community. Frequency of illness and the agents involved.

A S Monto1, K M Sullivan.   

Abstract

Investigations of respiratory illnesses and infections in Tecumseh, Michigan, USA, were carried out in two phases, together covering 11 years. During the second phase, there were 5363 person-years of observation. Respiratory illness rates in both males and females peaked in the 1-2 year age group and fell thereafter. Adult females had more frequent illnesses than adult males; illnesses were less common in working women than in women not working outside the home. Isolation of viruses fell with increasing age; rhinoviruses were the most common isolate. Influenza infection rates, determined serologically, suggested relative sparing of young children from infection with type A (H1N1) and type B. Infection rates were highest in adult age groups for type A (H3N2). The isolation and serological infection rates were used to estimate the extent to which laboratory procedures underestimated the proportion of respiratory illnesses caused by each infectious agent; data from other studies were also used in this estimation. Severity of respiratory illnesses was assessed by the proportion of such illnesses that resulted in consultation of a physician. Rhinoviruses produced the greatest number of consultations. Overall, physician consultations were associated with 25.4% of respiratory illnesses.

Entities:  

Mesh:

Year:  1993        PMID: 8432318      PMCID: PMC2271959          DOI: 10.1017/s0950268800050779

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  26 in total

Review 1.  Acute respiratory infection in children of developing countries: challenge of the 1990s.

Authors:  A S Monto
Journal:  Rev Infect Dis       Date:  1989 May-Jun

2.  Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes.

Authors:  A S Monto; E R Bryan; S Ohmit
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

3.  Respiratory syncytial virus in a community population: circulation of subgroups A and B since 1965.

Authors:  A S Monto; S Ohmit
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

Review 4.  Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.

Authors:  R L Tominack; F G Hayden
Journal:  Infect Dis Clin North Am       Date:  1987-06       Impact factor: 5.982

Review 5.  The common cold: control?

Authors:  R B Couch
Journal:  J Infect Dis       Date:  1984-08       Impact factor: 5.226

6.  Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981.

Authors:  A S Monto; J S Koopman; I M Longini
Journal:  Am J Epidemiol       Date:  1985-06       Impact factor: 4.897

7.  Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness.

Authors:  J P Fox; M K Cooney; C E Hall; H M Foy
Journal:  Am J Epidemiol       Date:  1982-08       Impact factor: 4.897

8.  Influenza A/Brazil/78(H1N1) infection in the elderly.

Authors:  U Mathur; D W Bentley; C B Hall; F K Roth; R G Douglas
Journal:  Am Rev Respir Dis       Date:  1981-06

9.  Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.

Authors:  C B Hall; J T McBride; E E Walsh; D M Bell; C L Gala; S Hildreth; L G Ten Eyck; W J Hall
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

10.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

View more
  132 in total

1.  A 20-year ecological study of the temporal association between influenza and meningococcal disease.

Authors:  Elise Snitker Jensen; Søren Lundbye-Christensen; Susanne Samuelsson; Henrik Toft Sørensen; Henrik Carl Schønheyder
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Health impact of influenza in the United States.

Authors:  K M Sullivan
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

3.  Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model.

Authors:  Rosalind M Eggo; James G Scott; Alison P Galvani; Lauren Ancel Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

4.  Three-year (1999-2002) of epidemiological and virological surveillance of influenza in north-east Italy.

Authors:  F Ansaldi; P D'Agaro; P Burgnich; D de Florentiis; S Favero; G Dal Molin; M Comar; N Coppola; C Campello
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  Repeated influenza vaccination of healthy children and adults: borrow now, pay later?

Authors:  F Carrat; A Lavenu; S Cauchemez; S Deleger
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

Review 6.  Vaccines for the common cold.

Authors:  Daniel Simancas-Racines; Juan Va Franco; Claudia V Guerra; Maria L Felix; Ricardo Hidalgo; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

7.  Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4.

Authors:  Silvina Coviello; Vera Wimmenauer; Fernando P Polack; Pablo M Irusta
Journal:  Hum Vaccin Immunother       Date:  2014-11-19       Impact factor: 3.452

Review 8.  Role of influenza vaccine for healthy children in the US.

Authors:  Stan L Block
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 9.  Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination.

Authors:  David G Meyers
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

10.  A previously undescribed coronavirus associated with respiratory disease in humans.

Authors:  Ron A M Fouchier; Nico G Hartwig; Theo M Bestebroer; Berend Niemeyer; Jan C de Jong; James H Simon; Albert D M E Osterhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.